{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:18:09Z","timestamp":1789730289840,"version":"4.0.1"},"reference-count":62,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recently, we have discovered several alternative circRNAs produced by alternative circularization of the primary transcripts of the apoptosis-related BAX gene. Among them, only three circRNAs, namely circ-BAX-6c, circ-BAX-18 and circ-BAX-74, are expressed in all studied triple-negative breast cancer (BrCa) cell lines and in the normal one; moreover, circ-BAX-18 is the only one comprising a novel microexon with canonical splice sites. Therefore, in this study, we examined circ-BAX-18 expression in BrCa tissues and its potential association with tumor features and patients\u2019 prognosis. For this purpose, tumor samples from a cohort of 144 female BrCa patients were used, along with paired non-cancerous breast tissue for 14 cases. circ-BAX-18 expression levels were quantified using an optimized, in-house-developed quantitative real-time PCR assay. Extensive biostatistical analysis was performed, including survival analysis. The expression of circ-BAX-18 differed among the 14 pairs of normal and cancerous breast tissues (p = 0.002). On the other hand, circ-BAX-18 expression did not appear to be associated with any clinicopathological characteristics. After splitting at the median value, higher circ-BAX-18 expression was rather associated with poorer disease-free survival (p = 0.009) and overall survival (p = 0.012) of BrCa patients. According to the multivariate Cox regression analysis results, the prognostic value of circ-BAX-18 positivity was rather independent of the other established predictors of prognosis incorporated in the Cox regression models, such as the molecular subtype of the tumors and the prognostic stage of the disease (regarding DFS: HR = 2.53, 95% CI = 1.30\u20134.92, p = 0.006; regarding OS: HR = 2.32, 95% CI = 1.20\u20134.49, p = 0.012). Moreover, the stratification of patients based on prognostic staging showed that high circ-BAX-18 expression may distinguish among stage II patients those with worse prognosis. In conclusion, increased circ-BAX-18 expression in BrCa is most likely associated with poor prognostic outcomes.<\/jats:p>","DOI":"10.3390\/ijms27104160","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:15:07Z","timestamp":1778156107000},"page":"4160","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation of a Circular BAX Transcript in Breast Cancer Is Associated with Unfavorable Prognosis"],"prefix":"10.3390","volume":"27","author":[{"given":"Vaia K.","family":"Stafyla","sequence":"first","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4725-648X","authenticated-orcid":false,"given":"Spyridon","family":"Christodoulou","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3920-2278","authenticated-orcid":false,"given":"Panagiotis","family":"Tsiakanikas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Michalopoulos","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic Surgery, \u201cHippokration\u201d General Hospital of Athens, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Danias","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-6813","authenticated-orcid":false,"given":"Panagiotis","family":"Kokoropoulos","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8461","authenticated-orcid":false,"given":"Christos K.","family":"Kontos","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0355-0417","authenticated-orcid":false,"given":"Nikolaos","family":"Arkadopoulos","sequence":"additional","affiliation":[{"name":"Fourth Department of Surgery, University General Hospital \u201cAttikon\u201d, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"GBD Breast Cancer Collaborators (2026). Global, regional, and national burden of breast cancer among females, 1990\u20132023, with forecasts to 2050: A systematic analysis for the Global Burden of Disease Study 2023. Lancet Oncol., 27, 302\u2013326.","DOI":"10.2139\/ssrn.6468038"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molonc.2010.04.004","article-title":"Histological types of breast cancer: How special are they?","volume":"4","author":"Weigelt","year":"2010","journal-title":"Mol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103862","DOI":"10.1016\/j.breast.2024.103862","article-title":"Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data","volume":"79","author":"Tang","year":"2025","journal-title":"Breast"},{"key":"ref_4","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4137\/CMO.S18006","article-title":"Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information","volume":"8","author":"Inic","year":"2014","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Xu, L., Xie, Y., Gou, Q., Cai, R., Bao, R., Huang, Y., and Tang, R. (2024). HER2-targeted therapies for HER2-positive early-stage breast cancer: Present and future. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1446414"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","article-title":"Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways","volume":"38","author":"Eroles","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Carvalho, E., Canberk, S., Schmitt, F., and Vale, N. (2025). Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. Cancers, 17.","DOI":"10.3390\/cancers17071102"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41419-019-1382-y","article-title":"circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p\/SOCS3 axis","volume":"10","author":"Xu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_11","first-page":"4503840","article-title":"Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study","volume":"2016","author":"Galasso","year":"2016","journal-title":"Int. J. Genom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"58595","DOI":"10.18632\/oncotarget.11193","article-title":"Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3","volume":"7","author":"Muhammad","year":"2016","journal-title":"Oncotarget"},{"key":"ref_13","first-page":"743","article-title":"Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911\/miR-449a pathway in breast carcinogenesis","volume":"52","author":"Wang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.7150\/thno.24106","article-title":"circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression","volume":"8","author":"Chen","year":"2018","journal-title":"Theranostics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","article-title":"The pro-metastasis effect of circANKS1B in breast cancer","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.06.007","article-title":"The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer","volume":"95","author":"Kansara","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41388-024-02950-4","article-title":"Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p\/ATG13\/ULK1 feedback loop","volume":"43","author":"Song","year":"2024","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00018-017-2688-5","article-title":"Molecular roles and function of circular RNAs in eukaryotic cells","volume":"75","author":"Holdt","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mustafa, M., Ahmad, R., Tantry, I.Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Hassan, M.I., and Habib, S. (2024). Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications. Cells, 13.","DOI":"10.3390\/cells13221838"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Qian, J., Zhao, L., Xu, L., Zhao, J., Tang, Y., Yu, M., Lin, J., Ding, L., and Cui, Q. (2024). Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179703"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/onc.2009.39","article-title":"BH3-only proteins in apoptosis and beyond: An overview","volume":"27","author":"Lomonosova","year":"2008","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.bbabio.2006.05.032","article-title":"Mitochondria as the target of the pro-apoptotic protein Bax","volume":"1757","author":"Er","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ghazimoradi, M.H., and Babashah, S. (2022). The role of CircRNA\/miRNA\/mRNA axis in breast cancer drug resistance. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.966083"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.7314\/APJCP.2014.15.20.8617","article-title":"Roles of the Bcl-2\/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel","volume":"15","author":"Sharifi","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_26","first-page":"4471","article-title":"Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma","volume":"55","author":"Krajewski","year":"1995","journal-title":"Cancer Res."},{"key":"ref_27","first-page":"325","article-title":"Bax\/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy","volume":"21","author":"Azimian","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"249372","DOI":"10.1155\/2014\/249372","article-title":"Evaluation of Bax and Bak gene mutations and expression in breast cancer","volume":"2014","author":"Kholoussi","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/2211-5463.13672","article-title":"Novel circular RNAs of the apoptosis-related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing","volume":"13","author":"Kontos","year":"2023","journal-title":"FEBS Open Bio"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00438-026-02388-1","article-title":"Discovery of novel circular RNAs of the apoptosis-related BAX gene in breast cancer, by combining nanopore and next-generation sequencing","volume":"301","author":"Katsaraki","year":"2026","journal-title":"Mol. Genet. Genom."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1038\/s41467-021-24975-z","article-title":"Nanopore sequencing of brain-derived full-length circRNAs reveals circRNA-specific exon usage, intron retention and microexons","volume":"12","author":"Rahimi","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.gde.2020.03.007","article-title":"Microexons: At the nexus of nervous system development, behaviour and autism spectrum disorder","volume":"65","author":"Blencowe","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ustianenko, D., Weyn-Vanhentenryck, S.M., and Zhang, C. (2017). Microexons: Discovery, regulation, and function. Wiley Interdiscip. Rev. RNA, 8.","DOI":"10.1002\/wrna.1418"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lei, H., Fu, J., Gu, W., Qiao, H., Guo, H., Chen, Z., Wang, S.M., and Chen, T. (2026). Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention. MedComm, 7.","DOI":"10.1002\/mco2.70560"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"80967","DOI":"10.18632\/oncotarget.13134","article-title":"Circular RNAs and their associations with breast cancer subtypes","volume":"7","author":"Nair","year":"2016","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.32604\/or.2023.046582","article-title":"Circular RNAs in breast cancer diagnosis, treatment and prognosis","volume":"32","author":"Huang","year":"2023","journal-title":"Oncol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: Opportunities and challenges in the field","volume":"37","author":"Kristensen","year":"2018","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bao, H., Li, J., Zhao, Q., Yang, Q., and Xu, Y. (2024). Circular RNAs in Breast Cancer: An Update. Biomolecules, 14.","DOI":"10.3390\/biom14020158"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, H., Gao, X., Yu, S., Wang, W., Liu, G., Jiang, X., and Sun, D. (2022). Circular RNAs regulate parental gene expression: A new direction for molecular oncology research. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.947775"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI118715","article-title":"Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice","volume":"97","author":"Bargou","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.2910600622","article-title":"Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis","volume":"60","author":"Bargou","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cbin.10100","article-title":"Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax","volume":"37","author":"Ji","year":"2013","journal-title":"Cell Biol. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","article-title":"Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis","volume":"303","author":"Chipuk","year":"2004","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11670-999-0018-7","article-title":"The expression and clinical value of apoptosis control gene Bcl-2 and bax in breast cancer","volume":"11","author":"Jun","year":"1999","journal-title":"Chin. J. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.cdd.4400675","article-title":"Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene","volume":"7","author":"Eguchi","year":"2000","journal-title":"Cell Death Differ."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/385637a0","article-title":"Bax suppresses tumorigenesis and stimulates apoptosis in vivo","volume":"385","author":"Yin","year":"1997","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chen, Q., Zhu, C., and Jin, Y. (2020). The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00093"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Campelo, M.M., Reis-das-Merces, L., Vidal, A.F., da Silva, F.R.P., de Oliveira, A.C.A., Monteiro, J.R.S., Cabral, C.G., Noronha, R.C.R., and Pereira, A.L. (2025). The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: A systematic review and computational approach. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1547889"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1478-811X-12-30","article-title":"Good guy or bad guy: The opposing roles of microRNA 125b in cancer","volume":"12","author":"Edbauer","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Sklirou, A.D., Gianniou, D.D., Karousi, P., Cheimonidi, C., Papachristopoulou, G., Kontos, C.K., Scorilas, A., and Trougakos, I.P. (2022). High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients\u2019 Relapse and Poor Survival. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179758"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s13277-014-2791-2","article-title":"Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer","volume":"36","author":"Jin","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Xue, C., Wei, J., Li, M., Chen, S., Zheng, L., Zhan, Y., Duan, Y., Deng, H., Xiong, W., and Li, G. (2022). The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer. Cells, 11.","DOI":"10.3390\/cells11193074"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gao, W., Pan, F., Qiu, K., Ou, C., Tian, F., and Yu, C. (2026). Divergent roles of circMPP6 and its parental gene MPP6 in non-small cell lung cancer. Front. Cell Dev. Biol., 14.","DOI":"10.3389\/fcell.2026.1722916"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"149684","DOI":"10.1016\/j.gene.2025.149684","article-title":"Research progress of circular RNA and N6-methyladenosine modification in colorectal cancer","volume":"967","author":"Xu","year":"2025","journal-title":"Gene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.21873\/anticanres.15019","article-title":"MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway","volume":"41","author":"Takao","year":"2021","journal-title":"Anticancer. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115522","DOI":"10.1016\/j.taap.2021.115522","article-title":"MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR\/ERK\/NF-kappaB signaling","volume":"420","author":"Tian","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1038\/s41598-021-90385-2","article-title":"MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro","volume":"11","author":"Normann","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2009.125377","article-title":"Understanding resistance to tamoxifen in hormone receptor-positive breast cancer","volume":"55","author":"Higgins","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","article-title":"Luminal A Breast Cancer and Molecular Assays: A Review","volume":"23","author":"Gao","year":"2018","journal-title":"Oncologist"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4741.2011.01175.x","article-title":"The paradox of triple negative breast cancer: Novel approaches to treatment","volume":"18","author":"Fornier","year":"2012","journal-title":"Breast J."},{"key":"ref_61","first-page":"vi35","article-title":"Neoadjuvant treatments for triple-negative breast cancer (TNBC)","volume":"23","author":"Martin","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4160\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:53Z","timestamp":1778156213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":62,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104160"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104160","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}